Screening of Prognostic Markers for Hepatocellular Carcinoma Patients Based on Multichip Combined Analysis

Figure 5

Analysis of DEmRNAs and clinical relationship and patients’ prognosis. (a) Heat map of 4 gene expressions in the high- and low-risk groups of risk model and clinicopathological differences between the two groups; (b) OS curves combined risk score and the patients’ different tumor stages, with the horizontal axis representing survival time and the vertical axis representing OS rate. Different color curves represent different combinations of risk and tumor stage. (c) Boxplots of differences in risk scores of different clinical stages, grades, and T stages.

(a)

(b)

(c)